Skip to main content
. 2022 Jun 10;11(12):1890. doi: 10.3390/cells11121890

Figure 7.

Figure 7

Working model for CAMKK2’s proposed tumor-extrinsic role in prostate cancer. We propose that Camkk2 KO in the liver and/or pancreas protects against metabolic syndrome. One consequence of this is lowered circulating insulin (or some insulin-like molecule), which slows early primary tumor growth and later metastatic colonization through decreasing cancer cell-intrinsic, oncogenic mTOR signaling.